Maki Komamine
4PUBLICATIONS
3CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (4)
Sort by Publication Date:
|Sep 06, 2024
PMDA Perspective on RWD/RWE Utilization for Regulatory Purposes Including Assessment on the Impacts of Regulatory Actions and Safety Risk of a Drug at Postmarketing Stage.Kazuhiro Kajiyama, Maki Komamine, Naoya Horiuchi
|Oct 31, 2023
Dealing with missing data in laboratory test results used as a baseline covariate: results of multi-hospital cohort studies utilizing a database system contributing to MID-NET® in Japan.Maki Komamine, Yoshiaki Fujimura, Masatomo Omiya
|Jun 06, 2021
Characteristics of hospital differences in missing of clinical laboratory test results in a multi-hospital observational database contributing to MID-NET® in Japan.Maki Komamine, Yoshiaki Fujimura, Yasuharu Nitta
|Jul 25, 2019
Cardiovascular risks associated with dipeptidyl peptidase-4 inhibitors monotherapy compared with other antidiabetes drugs in the Japanese population: A nationwide cohort study.Maki Komamine, Kazuhiro Kajiyama, Chieko Ishiguro
Pageof 1
